started · updated
Sleep apnea research highlights new therapies and health risks
Obstructive sleep apnea often remains undiagnosed, affecting individuals beyond the traditional risk profile of overweight men. Symptoms such as snoring, extreme daytime fatigue, and breathing pauses observed by partners can indicate the condition.
Medical research indicates a significant interaction between sleep apnea and diabetes. In diabetic patients, sleep apnea may increase the risk of microvascular complications, chronic kidney disease, and cardiovascular dysfunction through mechanisms like intermittent hypoxia and oxidative stress. Studies suggest that nighttime hypoxia levels may be a better predictor of cardiovascular events in diabetics than the traditional apnea-hypopnea index.
New therapeutic approaches are being explored, including the potential for oral medications to eventually replace CPAP masks. Additionally, two Phase 3 studies regarding Retatrutide have shown a reduction in breathing pauses.
Entities
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] Sleep apnea increases the risk of microvascular complications in patients with diabetes. www.ad-hoc-news.de
- [○ 1 SOURCE] Nighttime hypoxia levels may predict cardiovascular events in diabetics more effectively than the apnea-hypopnea index. www.ad-hoc-news.de
- [● 2 SOURCES] Snoring and daytime fatigue are potential signs of obstructive sleep apnea. www.fehmarn24.de · www.merkur.de
- [○ 1 SOURCE] Two Phase 3 studies of Retatrutide showed a reduction in breathing pauses. www.ad-hoc-news.de
- [● 2 SOURCES] Obstructive sleep apnea can affect individuals who do not fit the classic risk profile. www.fehmarn24.de · www.merkur.de